Date(s) - Jul 26, 2020 - Jul 31, 2020
VAPA 2020 Summer CME Conference
VAPA 2020 Summer CME Conference
July 26 - July 31, 2020 - Hilton Virginia Beach
Register now to take full advantage of our extensive schedule, networking opportunities, exhibit hall, and more!
- Transfer your registration to the virtual conference, and receive a partial refund for the difference in price.
- Cancel your registration and receive a full refund.
Notify Devon Possanza if you wish to CANCEL your registration by July 12. Otherwise, your registration will be transferred to the virtual conference and you will be issued the difference in price.
Your Questions, Answered!
When will the conference take place?
July 26 - 31, via Zoom
Will the lectures be live or recorded?
The lectures will be presented live, following the dates and times listed on the conference agenda. The sessions will not be recorded.
How do I view the presentations?
A few days before the conference, an email will be sent to attendees with a link to access all of the sessions. It will not be a different link each day.
If you have reserved a room at the Hilton, please call the reservation line at 757-213-3000, and choose option #1 to cancel. Please note: the reservation department is only open Thursday – Saturday, 9:00am – 5:00pm.
If you have any questions or need any additional information, please contact Devon Possanza - email@example.com
Considered the gold standard for the care of patients suffering from opioid use disorder, Medication-assisted treatment (MAT) is in high demand nationwide. To help meet this demand, the Physician Assistant Education Association, in partnership with the American Academy of Addiction Psychiatry, is offering VAPA conference attendees the opportunity to participate in 8-hours of live MAT waiver training remotely while earning up to 8 AAPA Category 1 CME credits.
By completing the first 8 hours of the 24 training hours required for PAs to obtain a waiver to prescribe buprenorphine in office-based settings, PAs will be able to:
• Screen and identify patients with OUD and define evidence-based treatments.
• Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
• Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
• Explain the process of buprenorphine induction as well as stabilization and maintenance.
• Discuss all FDA approved antagonist and agonist medications to treat OUD.
• Discuss basic office protocols including medical record documentation and confidentially.
• Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
• Recognize the importance of obtaining a waiver to begin treating patients with OUD.
To register for this virtual training event, visit https://services.easterassociates.com/conference/registration/VAPA/17.
For more information on MAT waiver training or resources on chronic pain and opioid use disorders (OUD), visit https://pcssnow.org/ or contact firstname.lastname@example.org. AAAP is the DATA 2000 sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Interprofessional Continuing Education (IPCE) Designation Statement: This activity was planned by and for the healthcare team, and learners will receive 8 (eight) Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement: American Academy of Addiction Psychiatry designates this live course for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192. This program is approved for up to 8 Nursing Contact Hours.
PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 41.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200648.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 6 AAPA Category 1 Self-Assessment CME credits. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200648.
For NCCPA certification maintenance ONLY: NCCPA will now apply an additional 50 percent weighting when these self-assessment credits are logged for NCCPA certification maintenance purposes. PAs should log up to a maximum of 6 AAPA Category 1 Self-Assessment CME credits, as the additional weighting will be automatically applied by NCCPA.